Details of the Drug Reposition

General Information of This Drug (ID: DMQUWXY)

Drug Name
CRLX101   DMQUWXY
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 2 [1]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 2 [2]
Ovarian cancer DISZJHAP 2C73 Phase 2 [2]
Renal cell carcinoma DISQZ2X8 2C90 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01803269) Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)